Abstract Five estrogenic hormones (unconjugated+conjugated fractions) and 10 beta blockers were analyzed in three wastewater treatment plant (WWTP) effluents and receiving river waters in the area of Lyon, France. In the different samples, only two estrogens were quantified: estrone and estriol. Some beta blockers, such as atenolol, acebutolol, and sotalol, were almost always quantified, but others, e.g., betaxolol, nadolol, and oxprenolol were rarely quantified. Concentrations measured in river waters were in the nanogram per liter range for estrogens and between 0.3 and 210 ng/L for beta blockers depending on the substance and the distance from the WWTP outfall. The impact of the WWTP on the receiving rivers was studied and showed a clear increase in concentrations near the WWTP outfall. For estrogens, the persistence in surface waters was not evaluated given the low concentrations levels (around 1 ng/L). For beta blockers, concentrations measured downstream of the WWTP outfall were up to 16 times higher than those measured upstream. Also, the persistence of metoprolol, nadolol, and propranolol was noted even 2 km downstream of the WWTP outfall. The comparison of beta blocker fingerprints in the samples collected in effluent and in the river also showed the impact of WWTP outfall on surface waters. Finally, a tentative environmental risk evaluation was performed on 15 sites by calculating the ratio of receiving water concentrations to predicted non-effect concentrations (PNEC). For estrogens, a total PNEC of 5 ng/L was considered and these substances were not linked to any potential environmental risk (only one site showed an environmental risk ratio above 1). Unfortunately, few PNECs are available and risk evaluation was only possible for 4 of the 10 beta blockers studied: acebutolol, atenolol, metoprolol, and propranolol. Only propranolol presented a ratio near or above 1, showing a possible environmental risk for 4 receiving waters out of 15.
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Introduction
Pharmaceuticals have been quantified worldwide at the nanogram per liter level in surface waters (Grujic et al. 2009; Kasprzyk-Hordern et al. 2009; Zhou et al. 2009 ).
Wastewater treatment plants (WWTPs) are recognized as the main entryway of these substances into the aquatic environment (Bendz et al. 2005; Castiglioni et al. 2006; Nakada et al. 2006 ). WWTPs are not designed to treat and remove pharmaceuticals, which are only degraded to some degree during sewage treatment (Miege et al. 2009b) . Beta blockers are a class of drugs used for various indications such as cardiac arrhythmias, hypertension, and cardioprotection after a heart attack. These pharmaceuticals are widely used in France, where, for example, more than 18 t of atenolol were consumed in 2004 (Besse et al. 2008) . Once consumed, beta blockers are excreted partly unchanged (Vieno et al. 2006; Hernando et al. 2007; Maurer et al. 2007 ). The consequences of their presence in the aquatic environment are not well-documented but the problem arised since beta-adrenergic receptors were found in fish (Haider and Baqri 2000) . Also, growth dysfunctions were observed on invertebrates in the presence of 0.5 mg/L of propranolol (Huggett et al. 2002) . Unlike beta blockers, estrogens can have a natural origin and are secreted daily by the human body (Ternes and Joss 2006) . They can also be consumed to treat, for example, menopausal problems or for contraception. In Europe, EE2, a synthetic estrogen, is commonly used in contraceptive pills; in 2004 in France, 40 kg of EE2 was consumed (Besse et al. 2008 ). These substances act as endocrine-disrupting compounds and can induce effects on fish reproduction from the nanogram per liter level (Hansen et al. 1998; Larsson et al. 1999; Jobling et al. 2003; GutjahrGobell et al. 2006) . Beta blockers in WWTP effluents and surface waters have already been studied (Ternes 1998; Andreozzi et al. 2003; Gros et al. 2006; Miege et al. 2006; Vieno et al. 2006) , but most of the analytical methods used are multiresidue methods (i.e., with a lower sensitivity) and only aimed at analyzing four or five beta blockers. In France, few data for concentrations in rivers are available (Andreozzi et al. 2003; Miege et al. 2006; Coetsier et al. 2009 ) and to our knowledge, no data are available for atenolol, nadolol, and sotalol, which are among the most hydrophilic beta blockers and widely used in France. Many studies have focused on estrogens and their analysis in effluents and surface waters (Baronti et al. 2000; Kuch and Ballschmiter 2001; Lagana et al. 2004; Vethaak et al. 2005; Morteani et al. 2006; Vigano et al. 2006; Loos et al. 2007; Kuster et al. 2008 ), but few have been conducted in France (Cargouet et al. 2004; Labadie and Budzinski 2005; Vulliet et al. 2008; Miege et al. 2009c) . Although some estrogens are often analyzed (such as E1, βE2, and EE2), others, such as αE2 and E3 are less frequently studied. Labadie and Budzinski (2005) studied the impact of a WWTP on its receiving river by analyzing estrogens. Samples were collected from 30 to 10 km downstream of a WWTP outfall, and the work focused on temporal and spatial steroid distributions along the river. Also, Castiglioni et al. (2006) studied the distribution and fate of pharmaceuticals (including atenolol, estrone, 17β-estradiol, and ethynylestradiol) in surface water receiving effluents from a WWTP; percentage attenuation in river water was also evaluated. However, these studies focused only on one site. In addition, Vieno et al. (2006) studied pharmaceuticals in two rivers impacted by a WWTP, but only four beta blockers were analyzed (acebutolol, atenolol, metoprolol, and sotalol). The authors compared concentrations at different sampling points in the river and estimated loss of the compounds by comparing the load in the downstream river with the loads from all the WWTPs located on the river. Finally, Miege et al. (2009a, b, c) proposed a risk evaluation study on five rivers impacted by effluent release. However, the study was based only on predictive environmental concentrations in rivers calculated from measured concentrations in effluent. Hence, further investigations are needed to improve our knowledge of the extent of river contamination caused by WWTP outfall, which may vary according to the geographical location or the type of WWTP.
The objective of this study was to evaluate the impact of selected French WWTPs on the receiving waters. We analyzed 10 beta blockers (acebutolol (ACE), atenolol (ATE), betaxolol (BET), bisoprolol (BIS), metoprolol (MET), nadolol (NAD), oxprenolol (OXP), propranolol (PROP), sotalol (SOT), and timolol (TIM)) and five estrogens (estrone (E1), 17α-estradiol (αE2), 17β-estradiol (βE2), estriol (E3), and ethynylestradiol (EE2)) selected for their high consumption, the data available in the scientific literature, or their toxicity. To evaluate the impact of WWTPs on receiving rivers, three sites located in the Lyon area were studied and both effluent and river samples were analyzed. For each site, concentrations measured in rivers upstream and downstream of the WWTP outfalls were compared. A tentative risk evaluation was performed for these three sites using either measured concentrations in rivers or predicted concentrations in rivers from measured concentration in effluents. This tentative risk evaluation was completed using results obtained on 12 WWTP effluents previously analyzed (Gabet-Giraud et al. 2010 ) and after calculation of predicted concentrations in downstream rivers.
Materials and methods

Sampling
To study the impact of WWTPs on surface waters, river water and effluent samples were collected at three sites (Beaujeu, Bourgoin-Jallieu, and Fontaines-sur-Saône; Fig. 1 ). Automatic 24-h composite samples were collected for effluent according to Gabet-Giraud et al. (2010) . Grab surface water samples were collected in 2.5 L amber glass bottles previously rinsed twice with the sample water. All the samples were stored at 4°C during transport to the laboratory. Filtering and extractions were performed within 24 h after sampling.
Three rivers located in the area of Lyon (France) were selected for this study (Fig. 1) . The River Saône (length, 480 km) is the main tributary of the River Rhône. The sampling site, near Fontaines-sur-Saône, is impacted by domestic and industrial contaminations. The River Ardières (length, 9.9 km) is a tributary of the River Saône. The site, near the town of Beaujeu, is impacted by different contamination sources: wastewater treatment plants, industry, and agriculture (mainly vineyards). The River Bourbre (length, 72.2 km) is another tributary of the River Rhône. This site, near the town of Bourgoin-Jallieu, is impacted by domestic and industrial contamination.
The characteristics of the WWTPs studied are presented in Table 1 . Two are equipped with a primary treatment system (primary settling). Biological treatments consist of activated sludge (conventional or medium rate) or a biological filter.
To study the impact of WWTPs, samples were collected in effluents and in rivers up-and downstream of the effluent outfall as described in Table 1 . For the River Bourbre, a more complex configuration required a different sampling methodology (Fig. 2) . The River Bourbre was sampled at one sampling point located 20 m upstream and two sampling points located 5 and 2,000 m downstream of the confluence with the Bion, which receives the WWTP effluent. The Bion was also sampled 2,000 m upstream of the WWTP outfall.
To obtain representative results, sampling was performed once per week for at least three consecutive weeks. 
Sample preparation and analysis
Water samples were first filtered through pyrolyzed (450°C, 1 h) glass fiber filters (GF/F, 0.7 μm pore size). The analytical method for the five estrogens is described elsewhere (Miege et al. 2009a) . Briefly, aliquots of filtrate spiked with deuterated estrogens (E1-D4, E2-D2, E3-D2, and EE2-D4) were extracted by solid-phase extraction (SPE) on Oasis HLB® cartridges and purified on Florisil cartridges. Extracts were evaporated to dryness and reconstituted in a solution of E2 acetate, used as an internal standard. For the analysis of total estrogens (i.e., after hydrolysis of conjugated forms), enzymatic cleavage was performed using β-glucuronidase isolated from Helix pomatia before extraction.
The 10 beta blockers were analyzed as described in GabetGiraud et al. (2010) . Briefly, aliquots of acidified filtrate were extracted by SPE on Oasis MCX® cartridges, evaporated to dryness and reconstituted in a solution of metoprolol impurity A, used as an internal standard. Aliquots of each sample were also spiked with the 10 beta blockers to define recoveries for each type of sample (i.e., river or effluent).
Analysis of estrogens and beta blockers was performed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) with acquisition in multiple reaction monitoring mode. As recommended in the EU Commission Decision 2002/657/EC, the MS-MS conditions included the use of two ionization transitions for each compound (except for the deuterated surrogates), one for quantification and one for identity confirmation.
Final estrogen concentrations were calculated using recoveries obtained for the internal deuterated surrogates (αE2 and βE2 were both corrected by E2D2). For beta blockers, final concentrations were calculated using recoveries obtained for the nondeuterated beta blockers in spiked samples: concentrations were corrected only if the recoveries were below 80 % or above 120 %.
Method limit of quantification (LOQ) was estimated for each substance/sample pair as described elsewhere (Miege et al. 2009a ). For E1, αE2, βE2, and E3, LOQ values ranged between 0.3 and 2.7 ng/L, it can reach 9.0 ng/L for EE2. For beta blockers, LOQ ranged between 0.2 and 1.1 ng/L.
Environmental risk evaluation
To evaluate the potential impact of each substance on the aquatic environment, we determined a quotient risk calculated as the ratio of a measured environmental concentration (MEC) to a predicted non-effect concentration (PNEC). When MEC is not available, a predicted environmental concentration (PEC) can be used (European Commission 2003) . An ecological risk is suspected when the ratio (MEC or PEC)/PNEC equals or exceeds 1 for a given substance.
A tentative risk evaluation was compared using either the MEC or the PEC obtained in the three rivers studied ("Calculation of PEC and comparison with MEC" section). This tentative risk evaluation was completed ("Tentative risk evaluation for the rivers downstream of 15 French WWTPs" section) for receiving rivers of 12 WWTPs located in France (Paris area, Lyon area, and in the south of France) using the PEC in rivers calculated from mean concentrations (n=2 or 3) For PEC calculation, fluxes of micropollutants were calculated (from concentrations measured in effluents and WWTP flow) and divided by the 5-year lowest water flow discharges of the receiving river (European Commission 2003) .
The 15 WWTPs (including the three studied in this paper) have various capacities (between 2,900 and 700,000 PE) and discharge their effluents into rivers of different sizes (from 0.02 to 600 m 3 /s).
Results and discussion
Occurrence of estrogens
The frequency of quantification and measured concentrations are presented in Table 2 . Three estrogens (αE2, βE2, and EE2) were never quantified in effluents or in surface waters. The most frequently quantified estrogen was E1, present in all the effluent samples and in 98 % of surface water samples. Concentrations of E1 ranged from 1.7 to 20 ng/L (mean, 1.6 ng/L) in effluent samples and from 0.3 to 3.9 ng/L (mean, 9.3 ng/L) in surface waters. Also, E1 is one of the estrogen present at the highest concentrations in influent samples (Gabet-Giraud et al. 2010) ; it is produced by biodegradation of βE2 and EE2 (Ternes et al. 1999a; Czajka and Londry 2006; Ren et al. 2007 ). E3 was quantified only in the effluent samples from Fontaines-sur-Saône WWTP, and in one of the nine samples collected in the River Saône downstream of the WWTP. The measured concentrations in the effluent samples were high (between 202 and 218 ng/L), but decreased to 26 ng/L in surface waters downstream from the WWTP.
In the literature, as here, αE2, βE2, and EE2 have not been quantified in effluent or in surface water (Boyd et al. 2003; Rodriguez-Mozaz et al. 2004; Labadie and Budzinski 2005; Farre et al. 2006; Kuster et al. 2008; Vulliet et al. 2008) . A recent review (Miege et al. 2009b) showed that E1 was quantified in 93 % of the effluent samples studied (n=79), at concentrations ranging between 0.6 and 95 ng/L (mean value, 20.9 ng/L), in agreement with our results. This review also showed that E3 was quantified in more than 90 % of the effluent samples (n=33); that is in the range of the maximum values reported in our study. Results from the literature confirmed a low quantification frequency of E3 in surface waters (Rodriguez-Mozaz et al. 2004; Labadie and Budzinski 2005; Farre et al. 2006; Kuster et al. 2008) . Reported concentrations of E3 in surface waters ranged from 1 to 50 ng/L (Morteani et al. 2006; Vigano et al. 2006; Kuster et al. 2008; Peng et al. 2008) . A study conducted on the Mississippi River in the USA (a site outside the direct influence of discharge points from WWTPs) and on Lake Pontchartrain (Louisiana, USA), showed that E1 was never detected (n=4, LOD=0.3 ng/L; Boyd et al. 2003) . In a recent survey conducted on several European rivers, including the Rivers Ardières and Bourbre, a quantification frequency of 16 % was reported for E1 (n=122, average concentration of 4 ng/L) (Loos et al. 2009 ); E1 was quantified at 3 ng/L in the River Bourbre, but was not quantified in the River Ardières. However, in this study, the LOD was relatively high for E1 (2 ng/L). By contrast, in a study conducted in Italy in the Rivers Po and Lambro, E1 was quantified in all samples (n=3) between 4 and 47 ng/L (Vigano et al. 2006) ; E3 was also quantified in all samples Eff effluent (n=8 for estrogens and beta blockers), SW surface water (n=42 for estrogens and 34 for beta blockers; αE2, βE2, EE2 never detected) (n=3) at concentrations ranging between 4 and 50 ng/L. In samples collected in the River Tamagawa and Lake Kasumigaura (Japan) receiving WWTP outfall, E1 was quantified systematically at concentrations between 0.2 and 3.8 ng/L (n=8) and E3 was never detected (LOD of 1.5 ng/L) (Isobe et al. 2003) . In France, a study conducted on an urban dam (receiving effluents from various WWTPs and industrial effluents) and a lake (supplied by different rivers from rural zones) in the Rhône-Alpes area showed that E1 was only quantified in one lake sample at 0.3 ng/L (Vulliet et al. 2008) . E1 was never detected in the River Seine, between 200 and 355 km downstream of the city of Paris (n=6, LOD between 0.3 and 8.0 ng/L depending on the analyte and the matrix; Labadie and Budzinski 2005), while it was quantified from 1.1 to 3.0 ng/L in all samples (n=6) collected in the Rivers Seine and Oise upstream and downstream (about 60 km) of Paris (Cargouet et al. 2004) . However, some studies reported higher concentrations; up to 65 ng/L in a Chinese river located in one of the most developed and densely populated areas of China (Peng et al. 2008 ). The differences between total (i.e., conjugated+unconjugated fractions) and unconjugated fractions of estrogens were not significant. The proportion of free (i.e., unconjugated) estrogens represented on average about 80 % of the total estrogens for effluent and surface waters. The differences between estrogen concentrations measured in samples with and without hydrolysis could be linked to the analytical uncertainty, which was estimated in the range of 20-50 % depending on the measured concentration. Thus, we can consider that most of the estrogens in surface water and effluent samples are present in the free form. Comparable results were obtained in surface water samples (Belfroid et al. 1999) . Estrogens are excreted by bodies in conjugated forms (glucuronide or sulfate) which are more soluble, but in activated sludge processes, cleavage (E1-3S in E1, and E2-17G in βE2) was observed (Ternes et al. 1999b; Baronti et al. 2000) .
Occurrence of beta blockers
Beta blockers were analyzed in 8 effluents and 34 surface water samples (Table 2) ; they were not measured in the River Saône sampled in June 2008. In effluent samples, ACE, ATE, BIS, MET, PROP, and SOT were always quantified. The other beta blockers, TIM, NAD, OXP, and BET were quantified in 88, 50, 38, and 25 % of effluent samples, respectively. The highest concentrations were observed for ATE, SOT, ACE, and PROP, with median concentrations above 138 ng/L. Median concentrations were lower than 50 ng/L for NAD, MET, BIS, and OXP, with only traces of TIM.
In surface waters, ACE, ATE, and SOT were the most frequently quantified beta blockers (>90 %), while NAD, BET, and OXP were only quantified in fewer than 32 % of the samples. BIS, MET, PROP, and TIM were quantified at intermediate frequencies (44-82 %) in surface water samples, respectively. ATE, ACE, and SOT were present at the highest median concentrations: 17, 14, and 5.5 ng/L, respectively. Median concentrations ranged between 0.3 and 4.6 ng/L for other beta blockers.
In the literature, ACE, ATE, BIS, MET, PROP, and SOT are generally quantified in effluent samples (>86 %) with mean concentrations ranging between 10 and 990 ng/L (Andreozzi et al. 2003; Vieno et al. 2006; Miege et al. 2009b) . Reported concentrations for a substance can vary widely from one country to another. For example, while MET was quantified at 80 ng/L (n=2) in France (Andreozzi et al. 2003) , concentrations between 910 and 1070 ng/L (n=3) were measured in Finland (Vieno et al. 2006) . For NAD and OXP, reported detection frequencies were higher than those observed in our study. In a study conducted in the USA, NAD was quantified in 71 % of the effluent samples (n=34) at a median concentration of 51 ng/L (Huggett et al. 2003) . Also, in a WWTP effluent monitoring campaign conducted in four European countries including France, OXP was quantified in 71 % of the samples (n=7; median concentration, 20 ng/L; Andreozzi et al. 2003) . On the contrary, while TIM was quantified in 88 % of the effluent samples in our study (mean concentration of 3.6 ng/L), it was only quantified in fewer than 7 % of German effluents (n=29); however, the LOQ in the German study was relatively high (25 ng/L; Ternes 1998). For BET, which was only quantified in 25 % of the effluent samples, a previous study in four European countries including France reported concentrations below LOD (Andreozzi et al. 2003) . However, the LOD were not detailed.
In surface water, various results have been reported. In a study conducted in the Rivers Po and Lambro, in the most densely inhabited and industrialized areas of Italy, ATE was quantified in all river samples (n=8) between 3.4 and 241 ng/L (Calamari et al. 2003) . By contrast, ATE was quantified only in 60 % of the samples collected in the River Vantaa, located in the most densely populated area of Finland, at concentrations between 12 and 25 ng/L (Vieno et al. 2006) ; the same study reported a quantification frequency of 80 % (n=5) for ACE, SOT, and MET with concentrations between 2 and 8, 15 and 52, and 20 and 116 ng/L, respectively. Conversely, a study performed in the River Seine in the Paris area quantified MET in only 30 % of the collected samples (n=10) at a mean concentration of 10 ng/L (Paffoni et al. 2006) ; ATE, SOT, PROP, and BIS were also analyzed (n=10; quantification frequency of 100, 100, 50, and 0 %, respectively) and measured with mean concentrations of 26, 45, 12, and <10 ng/L, respectively. For PROP, the same quantification frequency (50 %, n=6) was observed in a study conducted in the Rivers Taff (UK) and Warta (Poland) with measured concentrations between 5 and 6 ng/L (Kasprzyk-Hordem et al. 2007); ATE and MET were also found between 3 and 60, and 7 and 155 ng/L, respectively (quantification frequency of 67 and 50 %, respectively). In surface water collected in Spain in the Ebro river basin, MET and PROP were not detected (n=10, LOD of 3 and 2, respectively) and SOT and ATE were quantified at up to 70 and 250 ng/L, respectively (Gros et al. 2006) . Generally, reported concentrations of BIS, BET, NAD, MET, PROP, and TIM are below 10 ng/L (Ternes 1998; Gros et al. 2006; Paffoni et al. 2006 ). However, concentrations measured in surface water can reach high values: BIS and MET were quantified at above 2,000 ng/L in river water samples (Ternes 1998) .
Qualitative impact of WWTPs on surface waters
Generally, among the three sites studied, the River Bourbre was the one where the impact of the WWTP outfall was the most obvious ( Fig. 3; Supplementary material) . The WWTP outfall was the least diluted for this river: the average dilution factor (calculated as the ratio River flow/WWTP flow) was 14, against 70 and 7,000 for the Rivers Ardières and Saône, respectively.
For estrogens, because of the relatively low concentrations measured in effluent samples, the impact of WWTPs in Table 2) : αE2, βE2, and EE2 were never quantified; E3 only quantified in Fontaines-sur-Saône (in all effluents and in one surface water sample); BET and OXP only quantified in the samples from Fontaines-sur-Saône (mean concentrations below 2 ng/L for surface water and of 18 and 30 ng/L in effluents for BET and OXP, respectively); TIM only quantified at low levels (mean concentrations below 3 ng/L in surface water and between 2.9 and 8.7 ng/L in effluent samples) surface water was not significant; except in the River Bourbre, where the high concentration of E1 in the effluent (maximum of 16 ng/L) lead to a slight increase in E1 concentration in the river (from 1.6 to 2.5 ng/L, on average) immediately downstream from the WWTP. However, 2 km after the outfall of the WWTP (sampling point "downstream 2"), concentrations of E1 were equivalent to those measured upstream. E3 was only quantified in effluent samples of Fontaines-sur-Saône (average concentration, 210 ng/L) and in one sample collected downstream of the outfall (at 26 ng/L). As only low concentrations of E1 and too few data for E3 were measured in river water, the profile study and also the quantitative study of the impact of WWTPs on downstream rivers (see below) were not conducted on these hormones.
For beta blockers, the impact of WWTPs was also more visible in the River Bourbre. For example, the average concentration increased after the WWTP outfall from 14 to 99 ng/L for ACE, from 28 to 123 ng/L for ATE, and from 8.4 to 120 ng/L for SOT. In the River Saône, the average concentration increased from 14 to 76 ng/L for ACE, from 10 to 93 ng/L for ATE, and from 22 to 67 ng/L for SOT. For these two rivers, the increase in concentrations after the WWTP was also measurable for BIS, MET, and PROP. In the River Ardières, average concentrations increased from 9.1 to 39 ng/L for ACE and from 2.2 to 29 ng/L for ATE after the WWTP outfall (for ATE, concentration of upstream 1 was considered because of the abnormally high concentration in upstream 2). However, in the River Ardières, the concentration of SOT from WWTP effluent did not lead to a significant increase of concentration in the river (from 3.5 to 5.2 ng/L).
To evaluate the impact of WWTP outfall on river water quality, we compared the profile of the 10 beta blockers in effluent samples with those of river water upstream and downstream of the WWTP outfall. For each sampling point, the relative abundance of each substance was calculated by dividing its concentration by the sum of all beta blocker concentrations. This study was only conducted on samples from the River Bourbre as this was the site where the WWTP impact was the most visible (Fig. 4) . The river water collected immediately after the WWTP outfall (downstream 1) and the effluent had similar profiles, whereas the profile observed in river water collected upstream of the WWTP was different from the profile of the effluent sample. Moreover, the profiles of water samples collected upstream and downstream 2 were again similar, showing a return to upstream conditions 2 km downstream the WWTP outfall.
Quantitative impact of WWTP on surface waters
To evaluate quantitatively the observed gradient from upstream to downstream of the WWTP outfall, we calculated for beta blockers a ratio of increase as follows:
where C Downstream is the measured concentration in the river immediately downstream of the WWTP outfall and C Upstream is the measured concentration in the river immediately upstream of the WWTP outfall. When a significant increase was noted, an attenuation percentage was calculated as the difference in concentration between downstreams 1 and 2 as follows:
where C Downstream 1 is the measured concentration in the river immediately downstream of the WWTP outfall and C Downstream 2 is the measured concentration in the river at the second point downstream of the WWTP outfall. As shown in Table 3 , concentrations of beta blockers in surface waters downstream of the WWTP outfall can be up to 13 times higher than concentrations measured upstream. Concerning the four substances quantified in effluents at the highest concentrations (ACE, ATE, SOT, and PROP), concentrations increased by a factor of 3-13 in the River Bourbre, 0-12 in the River Ardières, and 2-8 in the River Saône. Also, the impact of WWTP outfall was generally greater on the River Bourbre than on the Rivers Saône or Ardières (except for ATE) because of the lower effluent dilution for the River Bourbre. For example, MET, which was quantified at similar concentrations in effluent from Beaujeu and Bourgoin-Jallieu WWTP (30-40 ng/L), showed a concentration six times higher in surface water after WWTP outfall in the River Bourbre, while no concentration variation was noted for the River Ardières. On the contrary, while ATE concentration was multiplied by 3 after WWTP outfall in the River Bourbre, it was, surprisingly, multiplied by 12 in the River Ardières; this result is linked to the high concentration of ATE measured upstream of the WWTP outfall in the River Bourbre (mean concentration 28 ng/L). For NAD and TIM, which were quantified at low concentrations in all effluent samples (<56 ng/L), the impact of the WWTP outfall was not detected on river concentrations. To study the fate and behavior of beta blockers in the downstream rivers, the attenuation of concentration between samples collected immediately after the effluent outfall (5 m) and samples collected further downstream (2,000 m for the River Bourbre and 20 m for the River Ardières) was evaluated. MET and PROP seemed to be the most persistent beta blockers since their attenuation was below 10 % at Bourgoin. Higher attenuations of concentration were noted for ACE at both sites: around 54 %. Considering the low hydrophobicity of this substance (log Kow, 1.42) (Detroyer et al. 2001) , it is not likely to be adsorbed on particulate matter. The attenuation of ACE may therefore be explained by degradation occurring in river water even only 20 m downstream of the effluent outfall; likewise for SOT, which was half degraded after 20 m. For ATE, while an attenuation of 61 % was noted in the River Bourbre (2,000 m), it was only 11 % in the River Ardières (20 m) because of a lower degradation. We observed that BIS was 61 % degraded after 2,000 m. No assertion is possible for NAD and TIM because measurements were too close to the LOQ. The analysis of particulate matter content and of samples collected at several points downstream of the effluent outfall would give a better understanding of the behavior and fate of beta blockers at these sites.
Effluent Downstream 1 Downstream 2 Upstream
A study reported in the literature on several pharmaceuticals (including ATE) also evaluated the attenuation between measured concentrations along the River Olona (Italy), 100 and 1,000 m downstream a WWTP outfall (Castiglioni et al. 2006) . It showed an attenuation of 29 % for ATE. Surprisingly, ATE was also detected in particulate matter, but exact content could not be quantified. Another study focused on the fate and behavior of several pharmaceuticals, including ACE, ATE, MET, and SOT, in the River Vantaa in Finland, downstream of several WWTP outfalls (Vieno et al. 2006) : Results showed the persistence of ATE and SOT (loss, ≤10 %) but a significant elimination of ACE and MET (loss, >60 %) along the river. The distance between the last WWTP and the sampling point in the river was much higher than in our study (above 10 km).
Calculation of PEC and comparison with MEC
To assess the representativity of PEC values, PECs in rivers (from effluent measurement) were compared with MECs in rivers (from river measurement, minimum and maximum values), for the three sites studied here (Table 4) . For E1, PECs were generally found in the same range as MECs for the River Bourbre. In contrast, for the Rivers Saône and Ardières, PECs for E1 were systematically underestimated compared with MECs (i.e., PECs 20 to 100 times lower than MECs in the River Saône, 3 to 16 times lower in the River Ardières). These differences can be explained by the presence of other WWTPs upstream of the target WWTP that could contribute to the total amount of micropollutants in the river. Concerning E3, which was only quantified in effluents from one of the three sites studied, PECs were close to LOQ, and therefore it is difficult to draw any firm conclusion. For beta blockers, in the Rivers Bourbre and Ardières, 77 % of PECs Environ Sci Pollut Res (2014 Res ( ) 21:1708 Res ( -1722 were higher than the corresponding MECs by a factor of 1.1-4. Nonetheless, for these rivers, a reasonably fit could generally be noted between PEC and MEC. In contrast, PECs calculated for beta blockers in the River Saône were generally underestimated, by a factor up to 30 for BIS. To conclude, the use of PEC is not completely reliable and, unexpectedly, it does not always represent the worst possible case; MEC values, when available, are to be preferred to PEC values.
Tentative risk evaluation for the rivers downstream of 15 French WWTPs
To evaluate the environmental risk linked to the presence of estrogens and beta blockers in French rivers, MECs for the three rivers studied here and PECs for the receiving rivers of the 12 WWTPs previously studied were compared for each substance with PNEC values found in the literature (Table 5) .
The PNEC values were computed from toxicity tests, but are available only for some of the substances studied. For estrogens, a rough estimation of PNEC at 5 ng/L was made (Stuer-Lauridsen et al. 2000) . For beta blockers, PNEC were available for only 4 of the 10 beta blockers analyzed. One author estimated EC50 (half maximal effective concentration) for ATE, MET and PROP on different species: an invertebrate (Daphnia magna), an alga (Desmodesmus subspicatus), and an aquatic plant (Lemna minor). The PNECs were obtained by dividing the lowest EC50 by an assessment factor of 1,000 (Cleuvers 2005) . The following results were obtained: PROP was the most toxic substance with a PNEC at 0.73 μg/L; the PNECs of ATE and MET were evaluated at 7.9 and 310 μg/L, respectively. Another study reported a PNEC derived from chronic tests on fish at 10 ng/L for PROP (Ferrari et al. 2004 ). For ACE, a PNEC was evaluated at 1250 μg/L on an invertebrate (Ceriodaphnia dubia) by dividing the lowest NOEC (chronic non-observed effect concentration) by 50 (Garric et al. 2006) . No PNEC value was found for NAD, but the toxicity tests performed on aquatic invertebrates showed that acute exposure to NAD at 100 mg/L resulted in no change in species survival (Huggett et al. 2002) . Thus, the following PNECs were used for this environmental risk evaluation study: 5 ng/L for total estrogens ("total" meaning the sum of estrogens), 1,250 μg/L for ACE, 7.9 μg/L for ATE, 310 μg/L for MET, and 10 ng/L for PROP.
For estrogens, total risk evaluation ratios evaluated with MECs of the three rivers studied ranged between 0.3 and 5.5 (Table 5 ). The atypical ratio of 5.5 is linked to the high concentration of E3 measured in one of the samples collected in the River Saône (25.9 ng/L). Among the receiving rivers of the 12 additional WWTPs studied, total risk evaluation ratios never exceeded 0.8. This shows a generally low predicted environmental risk associated with these substances in the systems studied.
Concerning beta blockers, for ACE, ATE, and MET, the ratio between MEC (or PEC) and PNEC were in most cases below 0.2, showing a nonsignificant predicted environmental risk. For PROP, the mean ratios were 0.3, 0.8, and 1.7 for the Rivers Ardières, Saône, and Bourbre, respectively (ratio between 0.1 and 0.7 for the River Ardières, between 0.3 and 2.5 for River Saône, and between 0.8 and 3.5 for River Bourbre). For PROP, among the receiving rivers of the 15 WWTP effluents presented in Table 5 , a ratio below 0.1 was calculated for two sites, while eight sites showed a ratio between 0.1 and 1, and five sites had a ratio higher than 1 and up to 34.2. These five sites correspond to the rivers where the WWTP effluents were the least diluted (Rivers Bourbre, Maurepas, Maldroit, Bouillide, and Ardières). From Table 5 , PROP may represent a potential environmental risk up to a dilution ratio of the effluent in the river of 13. A previous study performed on two large French rivers (the Saône and the Rhône) presented lower ratios PEC/PNEC for PROP: between 0.03 and 0.45 depending on the site studied (Miege et al. 2006) . In the present study, the fluxes of PROP were in the same range as those observed by Miege et al. (2006) but the 5-year lowest water flow discharges were 100 times lower.
Conclusion
Three different sites in the Lyon area of France were studied showing that among the five estrogens analyzed, only E1 and E3 were quantified in some effluents and river waters. The most frequently quantified estrogen was E1. The concentration of estrogen reached 220 ng/L in effluent (for E3) and 26 ng/L in river water (for E3). However, mean estrogen concentration in surface water was generally at the nanogram per liter level. Among the 10 beta blockers analyzed, ACE, ATE, and SOT were quantified in almost all the collected samples. Other substances, such as BET, NAD, and OXP, were rarely quantified. Beta blocker concentrations could reach up to 2,450 ng/L in effluent and 240 ng/L in surface water (for ATE), but mean concentrations of individual beta blocker in river water were below 50 ng/L.
The impact of WWTPs on the receiving rivers was manifest for all the sites studied, except for estrogens at Fontaines-surSaône, where the effluent was highly diluted in the river (dilution by nearly 7,000). Concentrations of estrogens and beta blockers generally increased downstream of the WWTP outfall; this was particularly the case on the River Bourbre, which was, among the different sites studied, the one where the effluent was the least diluted in the river. Downstream of the effluent outflow, the beta blocker concentrations could be up to 13 times higher than upstream of the WWTP. The study of the attenuation of concentration between samples collected immediately after the effluent outfall (5 m) and samples collected further downstream (20 or 2 km) showed that some beta blockers, such , 1,250,000 ng/L for ACE (Garric et al. 2006) , 7,900 ng/L for ATE (Cleuvers 2005) , 310,000 for MET (Cleuvers 2005) , and 10 ng/L for PROP (Ferrari et al. 2004) as MET and PROP, were not degraded even 2 km after the WWTP outfall, whereas others, like ACE were mostly degraded (more than 50 % of attenuation). The similarity of the relative distribution (i.e., fingerprint) of the beta blockers was shown between samples of effluent and river samples collected immediately downstream of the effluent outflow. An environmental risk evaluation was performed on 15 sites (including the three studied here). For estrogens, the total risk evaluation ratios were systematically below 1, except for one site, thus the low predictive environmental risk was low. With a ratio below 0.1, the predictive environmental risk linked to the presence of ATE, ACE, and MET in river water was negligible. On the contrary, ratios above 1 were obtained for PROP, showing a possible environmental risk for five sites. Beta blockers can represent a potential environmental risk up to a dilution ratio of the effluent in the river of 13. Unfortunately, as no PNEC was found for SOT, it was impossible to evaluate the risk linked to its presence in the aquatic environment, although we showed high concentrations in rivers. Even though potential toxicity due to individual beta blocker or estrogen was not proved here, the environmental risk evaluation presented here did not take into account synergistic, antagonist, or bioaccumulation effects.
